Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19.
J Clin Invest. 2021 Oct 15;131(20):e152264. doi: 10.1172/JCI152264.
J Clin Invest. 2021.
PMID: 34464358
Free PMC article.
Clinical Trial.